X-ray CT and pneumonia inhibition properties of gold-silver nanoparticles for targeting MRSA induced pneumonia.

Non-invasive assay for the early stage diagnosis of methicillin resistant Staphylococcus aureus (MRSA) related pneumonia is of great clinical importance and still a great challenge. In this paper, we reported a novel kind of Au@Ag core-shell theranostic nanoparticles (NPs) conjugated with MRSA specific antibody on their surface. Compared with the raw Au@Ag NPs, these antibody modified NPs (AAMA NPs) showed 10.66 fold enhancement targeting to the MRSA in vitro. In vivo target efficacy was measured with rats bearing pneumonia induced by different pathogens. Computed tomography (CT) results revealed that these AAMA NPs had higher CT contrast enhancement (498 HU), than those of raw Au@Ag and Omnipaque (oth <100 HU). In addition, lesions labeled by AAMA NPs could be distinguished from lung parenchyma by taking advantage of spectra CT. Bio-distribution analysis confirmed that these AAMA NPs accumulated in the MRSA rich site. Both BAL and Elisa assays indicated that these AAMA NPs greatly alleviated the inflammation reaction by reducing bacterial proliferation and cytokine production. Pathological study showed that these NPs exerted negligible long term cytotoxicity in vivo.

[1]  M. Copin,et al.  Characterization of an animal model of ventilator-acquired pneumonia. , 1999, Chest.

[2]  M. Kollef,et al.  Pneumonia caused by methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Chastre,et al.  Detection of Nosocomial Lung Infection in Ventilated Patients: Reply , 1989 .

[4]  Woo Kyung Moon,et al.  Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy. , 2011, AJR. American journal of roentgenology.

[5]  Ramiz A. Boulos,et al.  A novel antimicrobial agent reduces oxidative stress in cells , 2013 .

[6]  Mingwu Shen,et al.  Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. , 2011, Biomaterials.

[7]  R. Auckenthaler,et al.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. , 1991, The American review of respiratory disease.

[8]  N. Müller,et al.  Cryptogenic organizing pneumonia: CT findings in 43 patients. , 1994, AJR. American journal of roentgenology.

[9]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[10]  A. D. Watson,et al.  Metal-Based X-ray Contrast Media. , 1999, Chemical reviews.

[11]  L. Friedrich,et al.  Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. , 2007, The Journal of antimicrobial chemotherapy.

[12]  D. Hospenthal,et al.  Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Shengrong Guo,et al.  The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. , 2012, Biomaterials.

[14]  S. Buus,et al.  Tumor–associated antigens identified by mRNA expression profiling as tumor rejection epitopes , 2003, Journal of immune based therapies and vaccines.

[15]  T. Standiford,et al.  Early Recruitment of Neutrophils Determines Subsequent T1/T2 Host Responses in a Murine Model of Legionella pneumophila Pneumonia1 , 2001, The Journal of Immunology.

[16]  Zhengyang Zhou,et al.  Silver nanoshells as tri-mode bactericidal agents integrating long term antibacterial, photohyperthermia and triggered Ag+ release capabilities , 2013 .

[17]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[18]  W. Bennett,et al.  Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects , 1988, Clinical pharmacology and therapeutics.

[19]  R. Rodríguez-Roisín,et al.  Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. , 1993, The American review of respiratory disease.

[20]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[21]  M. Guiguet,et al.  Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. , 1988, The American review of respiratory disease.

[22]  F. Barone,et al.  Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. , 1994, Cerebrovascular and brain metabolism reviews.

[23]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.

[24]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[25]  F. DeLeo,et al.  An update on community-associated MRSA virulence. , 2009, Current opinion in pharmacology.

[26]  K. Schwartz,et al.  Panton–Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature , 2012, European Journal of Pediatrics.

[27]  M. Kollef,et al.  The effect of late-onset ventilator-associated pneumonia in determining patient mortality. , 1995, Chest.

[28]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[29]  E. Gorak,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  K. Hiramatsu.  Vancomycin resistance in staphylococci. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  Y. Nagai,et al.  Genome and virulence determinants of high virulence community-acquired MRSA , 2002, The Lancet.

[32]  T. Foster.  Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.

[33]  Zhengyang Zhou,et al.  Fabrication of Au@Ag core-shell NPs as enhanced CT contrast agents with broad antibacterial properties. , 2014, Colloids and surfaces. B, Biointerfaces.

[34]  V. Nizet.  Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. , 2007, The Journal of allergy and clinical immunology.

[35]  C. Chapman,et al.  Identification of an Immunodominant ABC Transporter in Methicillin-Resistant Staphylococcus aureusInfections , 2000, Infection and Immunity.

[36]  Carla Renata Arciola,et al.  Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. , 2012, Biomaterials.

[37]  R. Wunderink.  Detection of nosocomial lung infection in ventilated patients. , 1989, The American review of respiratory disease.

[38]  F. Saulnier,et al.  Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. , 1993, The American review of respiratory disease.

[39]  David Shimabukuro,et al.  Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model , 2003, Journal of immune based therapies and vaccines.

[40]  F. DeLeo,et al.  Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence , 2010, Journal of Molecular Medicine.

[41]  E. Marchiori,et al.  Swine-origin influenza A (H1N1) viral infection: thoracic findings on CT. , 2011, AJR. American journal of roentgenology.

[42]  K. Ohtomo,et al.  The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy‐based retrospective study of 48 patients , 2002, Mycoses.

[43]  Hong Xu,et al.  Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors. , 2014, Small.